These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26282464)

  • 1. Recent Patents on Nanoparticles and Nanoformulations for Cancer Therapy.
    Ray A; Mandal A; Joseph M; Mitra AK
    Recent Pat Drug Deliv Formul; 2016; 10(1):11-23. PubMed ID: 26282464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Patents on Polymeric Nanoparticles for Cancer Therapy.
    Pandey P; Dureja H
    Recent Pat Nanotechnol; 2018; 12(2):155-169. PubMed ID: 29589551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
    Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
    Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of gamma-polyglutamic acid nanoparticles for controlled anticancer drug release.
    Manocha B; Margaritis A
    Crit Rev Biotechnol; 2008; 28(2):83-99. PubMed ID: 18568849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patents in chemotherapy: nanoparticles as drug-delivery vehicles.
    Talat A; Khan AU
    Pharm Pat Anal; 2020 Jul; 9(4):117-119. PubMed ID: 32815487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges towards targeted delivery of cancer therapeutics.
    Rosenblum D; Joshi N; Tao W; Karp JM; Peer D
    Nat Commun; 2018 Apr; 9(1):1410. PubMed ID: 29650952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for surface modification of gelatin-based nanoparticles.
    Mahmoudi Saber M
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110407. PubMed ID: 31400613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
    Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
    Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for Cancer Targeting: Current and Future Directions.
    Swain S; Sahu PK; Beg S; Babu SM
    Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of nanoparticle shape in cancer drug delivery.
    Truong NP; Whittaker MR; Mak CW; Davis TP
    Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
    Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.
    Bose RJC; Ravikumar R; Karuppagounder V; Bennet D; Rangasamy S; Thandavarayan RA
    Drug Discov Today; 2017 Aug; 22(8):1258-1265. PubMed ID: 28600191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting.
    Freag MS
    Curr Pharm Des; 2017; 23(35):5283-5291. PubMed ID: 28552066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods for lipid nanoparticles preparation.
    Corrias F; Lai F
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):201-13. PubMed ID: 21834772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
    Battaglia L; Gallarate M
    Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
    Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
    Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Patents on Plant-Derived Nanoparticles and their Potential Application Towards Various Cancer Therapeutics.
    Santhosh SB; Shanmugarama S; Ramesh N; Tharik AMS; Basamshetty VV
    Recent Pat Anticancer Drug Discov; 2023; 18(3):292-306. PubMed ID: 35450532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.